VRDN Viridian Therapeutics, Inc.
Biotechnology NasdaqCM
Trading Signals
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $12.06
- Medium Support $12.82
- Weak Support $13.57
Resistance Levels
- Weak Resistance $15.09
- Medium Resistance $15.84
- Strong Resistance $16.59
Stop Loss Suggestions
- Conservative $15.94
- Moderate $15.46
- Aggressive $16.22
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | SELL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities
Quarterly Outlook
2025-07-01
Bullish Scenario
from current 25.82%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (14.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (45.52) is in bearish territory, indicating downward momentum. MACD line (-0.83) is above Signal line (-1.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.85, indicating the average weekly price range.
2025-07-01
Base Scenario
from current 3.23%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (14.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (45.52) is in bearish territory, indicating downward momentum. MACD line (-0.83) is above Signal line (-1.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.85, indicating the average weekly price range.
2025-07-01
Bearish Scenario
from current -25.82%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (14.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (45.52) is in bearish territory, indicating downward momentum. MACD line (-0.83) is above Signal line (-1.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.85, indicating the average weekly price range.
Annual Outlook
2025-07-01
Bullish Scenario
from current 51.64%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (14.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (45.52) is in bearish territory, indicating downward momentum. MACD line (-0.83) is above Signal line (-1.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.85, indicating the average weekly price range.
2025-07-01
Base Scenario
from current 6.45%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (14.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (45.52) is in bearish territory, indicating downward momentum. MACD line (-0.83) is above Signal line (-1.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.85, indicating the average weekly price range.
2025-07-01
Bearish Scenario
from current -51.64%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (14.19) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (45.52) is in bearish territory, indicating downward momentum. MACD line (-0.83) is above Signal line (-1.14) (bullish crossover), confirming upward momentum. Current Weekly ATR is 1.85, indicating the average weekly price range.
Technical Analysis
Trend Identification
EMA
Exponential Moving Average
Current price (14.33) is between Short MA (14.84) and Long MA (13.58), or near one of them. This suggests consolidation or mixed signals. Short MA (14.84) is above Long MA (13.58), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (14.84, 13.58, 14.53) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.1500) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). A bearish crossover above the zero line can indicate a reversal from a prior uptrend. Consider this as a potential early sell signal.
ADX
Average Directional Index
ADX (22.88) indicates a developing or weakening trend. +DI (16.07) is above -DI (15.81), suggesting a bullish directional bias. Be cautious with current positions. Monitor for trend continuation or reversal signals.
Momentum Measurement
RSI
Relative Strength Index
RSI (47.58) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV
On-Balance Volume
OBV (12955234.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic
Stochastic Oscillator
Stochastics (%K: 36.91, %D: 34.86) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed, potentially signaling an upward trend reversal or continuation. Stronger signal if this occurs below 50.
CCI
Commodity Channel Index
CCI (-92.92) is between -100 and 0. This indicates bearish momentum is present, but not yet extreme. A move below 0 from positive territory (bearish zero-line cross) can indicate a potential sell signal.
Volatility Measurement
ATR
Average True Range
Current ATR is 0.7500. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands
Volatility Bands
Current price (14.33) is within the Bollinger Bands (13.58 - 16.10). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (14.84), indicating short-term bearish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals
SAR
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 15.94 is 11.24% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
RSI
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Stochastic
Neutral
Stochastic is in neutral territory (36.9). No clear overbought/oversold signal.
Bollinger Bands
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the lower half of the bands, suggesting a bearish bias.No indication of imminent volatility expansion or reversal.
Holder List (Top 20)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| FMR, LLC | INSTITUTIONAL | 12222986 | 14.98% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 5708110 | 7% | 2025-03-31 |
| Deep Track Capital, Lp | INSTITUTIONAL | 5380449 | 6.59% | 2025-03-31 |
| Kynam Capital Management, LP | INSTITUTIONAL | 4700000 | 5.76% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 4563100 | 5.59% | 2025-03-31 |
| VR Adviser, LLC | INSTITUTIONAL | 3882709 | 4.76% | 2025-03-31 |
| Commodore Capital Lp | INSTITUTIONAL | 3600000 | 4.41% | 2025-03-31 |
| Fairmount Funds Management LLC | INSTITUTIONAL | 3445813 | 4.22% | 2025-03-31 |
| State Street Corporation | INSTITUTIONAL | 2865500 | 3.51% | 2025-03-31 |
| Tang Capital Management, LLC | INSTITUTIONAL | 2792925 | 3.42% | 2025-03-31 |
| Fidelity Select Portfolios-Health Care Portfolio | MUTUALFUND | 2582408 | 3.17% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 2219731 | 2.72% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 1840924 | 2.26% | 2025-04-30 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | MUTUALFUND | 1736110 | 2.13% | 2025-04-30 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | MUTUALFUND | 1524825 | 1.87% | 2025-04-30 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 1265601 | 1.55% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 1067262 | 1.31% | 2025-03-31 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | MUTUALFUND | 1054475 | 1.29% | 2025-02-28 |
| T. Rowe Price New Horizons Fund, Inc. | MUTUALFUND | 972508 | 1.19% | 2025-03-31 |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | MUTUALFUND | 907173 | 1.11% | 2025-04-30 |